Top Markets
#1 Black Phoenix Black Phoenix +367.76%
#2 Islamic Coin Islamic Coin +158.17%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.01%
#5 Akedo Akedo +34.74%
#6 BasedHype BasedHype +29.66%
#7 Acurast Acurast +29.41%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#9 Cryptopia Cryptopia +21.42%
#10 GoPlus Security GoPlus Security +21.39%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Physiomics Plc Physiomics Plc

Physiomics Plc

PYC
Rank in Stocks #41443
Founded in 2001 and headquartered in Oxford, UK, Physiomics Plc offers expert... Founded in 2001 and headquartered in Oxford, UK, Physiomics Plc offers expert consulting services to pharmaceutical enterprises across the United Kingdom, the United States, and the European Union. The company's core specialization lies in outsourced quantitative pharmacology and computational biology. They deliver comprehensive modeling, simulation, and data analysis services primarily focused on oncology research and development, utilizing their proprietary Virtual Tumour predictive software. Additionally, Physiomics is engaged in developing innovative technologies for applications within the field of personalized medicine.
Share Price
$0.00605512
Market Cap
$20.35K
Change (1 day)
0.00%
Change (1 year)
4.92%
Country
GB
Trade Physiomics Plc (PYC)

Category

Healthcare
Revenue for Physiomics Plc (PYC)
Revenue in Aug 2026 TTM: 0
According to Physiomics Plc latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Physiomics Plc from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE